Share on StockTwits

Shares of HCP (NYSE:HCP) were the target of unusually large options trading on Wednesday. Stock traders acquired 16,309 call options on the stock, reports. This represents an increase of approximately 1,003% compared to the typical volume of 1,479 call options.

A number of research firms have recently commented on HCP. Analysts at Jefferies Group upgraded shares of HCP from a “hold” rating to a “buy” rating in a research note to investors on Thursday, January 9th. They now have a $41.00 price target on the stock, down previously from $43.00. Separately, analysts at Barclays cut their price target on shares of HCP from $49.00 to $39.00 in a research note to investors on Wednesday, January 8th. They now have an “equal weight” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of HCP in a research note to investors on Tuesday, November 26th. They now have a $40.00 price target on the stock. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $44.91.

HCP (NYSE:HCP) traded up 1.22% during mid-day trading on Thursday, hitting $38.52. The stock had a trading volume of 218,448 shares. HCP has a 1-year low of $35.50 and a 1-year high of $56.06. The stock has a 50-day moving average of $37.63 and a 200-day moving average of $40.00. The company has a market cap of $17.576 billion and a price-to-earnings ratio of 18.92.

The company also recently declared a dividend, which is scheduled for Tuesday, February 25th. Investors of record on Monday, February 10th will be given a dividend of 0.525 per share. The ex-dividend date of this dividend is Thursday, February 6th.

HCP, Inc (NYSE:HCP) is a real estate investment trust (REIT).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.